Eduardo Lanza
Papers
2
Total Citations
9
H-Index
2
About
Eduardo Lanza is a leading surgical oncologist whose research focuses on the optimal management of pancreatic neuroendocrine tumors (pNETs), a rare and complex subset of pancreatic cancer. His major contributions center on refining surgical decision-making for both functional and non-functional pNETs, advocating for a multidisciplinary approach that balances oncologic efficacy with quality of life. Lanza’s work critically evaluates surgical options—from enucleation to distal pancreatectomy—providing evidence-based guidance for when each technique is most appropriate, particularly for patients diagnosed at advanced stages. His most-cited paper, “Pancreatic Neuroendocrine Tumors: What Is the Best Surgical Option?” (2024), has accumulated 9 citations, reflecting its immediate relevance in a field where consensus on surgical strategy remains elusive. By synthesizing clinical outcomes and hormonal syndromes, Lanza has helped clarify the role of aggressive versus conservative surgery, influencing treatment protocols in specialized centers. His research is essential reading for surgeons and oncologists navigating the challenges of pNET management, and his work continues to shape the conversation around personalized, multidisciplinary care for these rare tumors.
Research Focus
Key Achievements
Top Papers
- 1Pancreatic Neuroendocrine Tumors: What Is the Best Surgical Option?5 citations · 2024
- 2Pancreatic Neuroendocrine Tumors: What Is the Best Surgical Option?4 citations · 2024